Mar. 23 -- FRIDAY, March 30 (HealthDay News) -- Zelnorm, a drug to treat constipation associated with irritable bowel syndrome, has been taken off the market because of an increased risk of heart ...
MiraLAX (polyethylene glycol 3350) is an over-the-counter drug used to treat constipation in adults and certain children. MiraLAX can interact with some supplements and other medications, including ...
Verywell Health on MSN

Can Constipation Cause Acid Reflux?

Constipation can cause acid reflux because straining to pass a bowel movement puts pressure on the abdomen, which can trigger ...
Oprah Winfrey says she had one big main side effect from taking a GLP-1 weight-loss drug: constipation. She reveals the ...
Out of 11078 subjects invited to the health survey, 6141 participated. In the participants and non-participants the proportions of women was 55% and 45% respectively, and mean age was 49.2 and 45.0 ...
Topamax (topiramate) may cause various side effects, including constipation, in some people. While not a common issue, knowing how to manage constipation and related side effects can help you continue ...
A new drug called linaclotide can reduce symptoms of chronic constipation for some patients, according to a report in the New England Journal of Medicine. In two trials of linaclotide, about 21 ...
MiraLAX (polyethylene glycol 3350) is a brand-name powder that’s used for constipation. MiraLAX has interactions with some other drugs and certain supplements. Examples include loop diuretics and ...
(Reuters) - Biotechnology company Alkermes Plc said it would stop development of its experimental drug to treat opioid-induced constipation after it failed to meet the main goal of a mid-stage study.
Shares of Lupin Ltd gained up to 1.5% to Rs 1959.70 after the pharmaceutical company announced a significant achievement with the approval from the United States Food and Drug Administration (USFDA) ...
(Reuters) - Ironwood Pharmaceuticals Inc said a lower dose of its constipation drug met the main goal of improving bowel movements of patients in a late-stage study. The company's shares rose as much ...